We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

IONTAS Announces New Antibody Optimisation Agreement with Teva Pharmaceuticals

Product News   Jul 31, 2019

 
IONTAS Announces New Antibody Optimisation Agreement with Teva Pharmaceuticals
FURTHER INFORMATION
 
 
 

Related Product News

Antibody Enters Clinical Trial for Treatment of B Cell Acute Lymphoblastic Leukemia

Product News

IONTAS has been informed that International Biotechnology Center (IBC) Generium has received approval from the Russian Health Authorities to initiate clinical trials with its CD3/CD19 bispecific antibody for the treatment of B Cell Acute Lymphoblastic Leukemia (ALL).

READ MORE

Drug Therapy for Demyelinating and Neuroinflammatory Diseases Given US Patent

Product News

MetP Pharma has announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its patent entitled “Treatment of Demyelinating Diseases”.

READ MORE

ScreenIn3D Wins ELRIG Drug Discovery Innovation Prize

Product News

ScreenIn3D, a partner of AMSBIO, has been awarded the ELRIG Prize for Innovation in Drug Discovery at their flagship conference Drug Discovery 2019.

READ MORE

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE